1.47 mg of RSV preF with 1.45 mg of MxR Fab were mixed and incubated overnight at 4 °C with gentle rocking, before SEC purification over a 10/300 Superose 6 column (Cytiva, cat#29091596). A very broad peak eluted, with the nine largest fractions concentrated to 0.22 mg/mL using a 10 kDa cutoff Amicon ultrafiltration unit (Sigma-Aldrich, cat#UFC8030). For 3 × 1, we incubated 50 µg of HPIV3 preF with 150 µg of 3 × 1 Fab overnight at 4 °C with gentle rocking before SEC purification over a Superdex 200 16/600 SEC column (Cytiva, cat#28989335). A single narrow high molecular weight peak was eluted and was concentrated to 0.4 mg/mL using a 10 kDa cutoff Amicon ultrafiltration unit.
Both complexes were frozen on Quantifoil 1.2/1.3 UltrAu 300 mesh grids (Electron Microscopy Sciences, cat#Q350AR13A) using a Vitrobot Mk. IV (Thermo Fisher) at 22 °C and 100% humidity. Dodecyl-β-d-maltoside (DDM) was added to the sample (0.05% final concentration) 30 min prior to the start of freezing, and a PELCO easiGlow™ (Tedpella, Cat#91000) was used to glow discharge the grids. The final MxR:RSV grids used for the collection were frozen with 4 µL of the sample at 0.21 mg/mL, a 14 s blot time, 0 blot force, and a 5 s wait between application and blotting. The final 3 × 1:HPIV3 grids used for the collection were frozen with 4 µL of the sample at 0.19 mg/mL, a 12 s blot time, 0 blot force, and a 15 s wait between application and blotting.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.